Nitazenes in the UK: A Hidden Risk in an Unpredictable Drug Supply

What are nitazenes and why are they a growing concern in the UK?

Nitazenes are a group of highly potent synthetic opioids that are increasingly being detected in the UK drug supply. Originally developed in the 1950s as potential painkillers, they were never approved for medical use due to their extreme strength and risk of overdose.

Recent data from the UK Health Security Agency and the Office for Health Improvement and Disparities show an increasing number of deaths involving potent synthetic opioids, including nitazenes, across the UK.

Some nitazenes are believed to be many times stronger than heroin, meaning even a very small amount can slow or stop breathing.

How are nitazenes entering the UK drug supply?

Nitazenes are entering the UK through illicit global supply chains, including online markets and organised distribution networks.

According to the European Union Drugs Agency, synthetic opioids are becoming more common because they are:

• Cheaper to produce than plant-based drugs like heroin

• Easier to transport in small quantities

• Highly potent, increasing profitability

In the UK, nitazenes have been found in:

• Heroin and opioid-type substances

• Counterfeit prescription medications (e.g. fake diazepam and oxycodone)

• Unknown powders and pills sold online or on the street

Can nitazenes be found in cocaine?

There is emerging evidence and growing concern that nitazenes are not limited to opioid drugs.

UK drug alerts and European monitoring reports warn that nitazenes may be present in other substances, including cocaine. This is most likely due to:

• Cross-contamination during production or packaging

• Shared equipment across drug types

• Unpredictable supply chains

While this is not currently widespread, it represents a serious risk.

People who use cocaine typically have no opioid tolerance, meaning even a trace amount of a nitazene could lead to a rapid and unexpected overdose.

Why are nitazenes so dangerous?

The key risk is a combination of extreme potency and unpredictability.

According to UK public health guidance:

• There is a very small margin between a dose and a fatal overdose

• People often do not know they are taking nitazenes

• Effects can occur very quickly, reducing time to respond

This means individuals can unknowingly consume a life-threatening substance—even when taking something they believe is familiar.

Is this likely to become more widespread?

Public health bodies are increasingly concerned that this issue could grow.

The European Union Drugs Agency has highlighted the rise of synthetic opioids and polysubstance use as a key emerging threat across Europe.

This pattern mirrors trends seen in North America, where substances like Fentanyl crisis spread rapidly across multiple drug types, contributing to large increases in overdose deaths.

The UK is currently at an early stage, where awareness and intervention can help prevent wider harm.

What can people do to reduce risk?

While no illicit drug use is without risk, harm reduction advice from UK health services includes:

• Carrying naloxone (an opioid overdose reversal medication)

• Avoiding using drugs alone

• Starting with a very small amount

• Checking on others regularly

• Calling emergency services immediately if someone becomes unwell

Being honest about what has been taken can help emergency responders act quickly and save lives.

Why this matters for communities and public health

The rise of nitazenes reflects a broader shift toward a more volatile and unpredictable drug market.

For community leaders and public health professionals, this highlights the need for:

• Clear, accessible education and awareness

• Early warning systems and data sharing

• Culturally responsive support services

• Open conversations to reduce stigma and encourage help-seeking

  
  

This is not just an issue affecting one group—it is a system-wide public health challenge.